MALT (psychedelic drug)

MALT

Clinical data
Other names	N,N-Methylallyltyptamine; (2-(1H-Indol-3-yl)ethyl)(methyl)(prop-2-en-1-yl)amine; 1H-Indole-3-ethanamine, N-methyl-N-2-propen-1-yl-; Malt
Legal status
Legal status	UK: Class A US: Analogue to a Schedule I/II drug
Identifiers
IUPAC name N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine
CAS Number	1366416-29-6
PubChem CID	155907915
ChemSpider	74902443
UNII	R3PSM6BEG8
CompTox Dashboard (EPA)	DTXSID501337077
Chemical and physical data
Formula	C14H18N2
Molar mass	214.312 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN(CCC1=CNC2=CC=CC=C21)CC=C
InChI InChI=1S/C14H18N2/c1-3-9-16(2)10-8-12-11-15-14-7-5-4-6-13(12)14/h3-7,11,15H,1,8-10H2,2H3 Key:GXCLVBGFBYZDAG-UHFFFAOYSA-N

MALT crystals

MALT (N-methyl-N-allyltryptamine or N,N-methylallyltryptamine) is a lesser-known drug from the tryptamine family. It is a novel compound with very little history of human use. It is closely related to methylpropyltryptamine (MPT), as well as N-methyltryptamine. It has been sold online as a designer drug. Very little information on the pharmacology or toxicity of MALT is available.

Legality

MALT is not explicitly scheduled in any countries; however, it could be considered a psychoactive substance under the UK Psychoactive Substances Act, which requires the prosecutor to prove that the substance is psychoactive in order for a person to be charged with an offense.

It could also be considered a structural analog of a scheduled substance under the US Federal Analogue Act due to its similarity to scheduled tryptamines.

See also

• 5-Methoxy-N,N-Methylallyltryptamine (5-MeO-MALT)
• N,N-Diallyltryptamine (DALT)
• Methylpropyltryptamine (MPT)

Further reading

• Chadeayne AR, Pham DN, Golen JA, Manke DR (August 2020). "DMT analogues: N-ethyl-N-propyl-tryptamine and N-allyl-N-methytryptamine as their hydro-fumarate salts". Acta Crystallographica Section E: Crystallographic Communications. 76 (Pt 8): 1201–1205. doi:10.1107/S2056989020008683. PMC 7405555. PMID 32843999.
• Brandt SD, Freeman S, Fleet IA, McGagh P, Alder JF (November 2004). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS". The Analyst. 129 (11): 1047–1057. Bibcode:2004Ana...129.1047B. doi:10.1039/b407239c. PMID 15508033.